mark draper graphic design portfolio 2015
DESCRIPTION
ÂTRANSCRIPT
Mark Draper - 2014-15 Portfolio
How to create your 2015 strategy, communications and engagement plan
in 24 hours
CONCEPT and VALUE
CONCEPT
Each member of the leadership team will be collected from home and driven to a secret location. For the next 24 hours they will be put through their paces by a world-class facilitation team, helping them to create the 2015 strategy, also challenging their thinking on priorities and the ‘must win’ battles.
THE VALUE
1 Your organization will have a comprehensive 12 month strategy which is aligned to the customer, employee and organizational goals
2 Through this process You will gain alignment with your executive team
3 Through this process You will create a high performance leadership team. 4 The output of this process will provide you with a tool to enable greater engagement with the strategy throughout your organization.
Introducing the
BIG PICTURE
LAUNCH OFCOMMUNICATION 1LOCKDOWN 24RESEARCH AND
PREPERATION
LAUNCH OFCOMMUNICATION 2
LAUNCH OFCOMMUNICATION 3
THE JOURNEY & VENUE
LAUNCH OFCOMMUNICATION 4
Example agenda
• Pre-Event - Define the position
• Pre-Event – Define the position
• Lockdown event design
• Lockdown Event
• Organization Communication
08:30
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
22:00
ACTIVITY
Arrival
Opening and setting the scene
What is our VMV (Vision/Mission/Value)
What will make us successful
Lunch
Action session 1
Action session 2
Action session 3
Let’s hear it from a knowledge expert
‘Brain shower’
Re-energize session
Working dinner
End of the day
DAY 1
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
ACTIVITY
Arrival
Day 1 review and questions
Building the plan part 1
Building the plan part 2
Lunch
Building the plan part 3
Building the plan part 4
Building the plan part 5
Review of the plan part 1
Review of the plan part 1
Close
Drinks and celebration
DAY 2
PRISON warehouse
luxury hotelship
THE PROJECTStrategy Issues - Identify strategic issues to address
Industry & Market Data - Identify market opportunities and threats Customer Insights - Assess current satisfaction and future demand
Employee Input - Determine strengths and weaknesses
SWOT - Synthesize the data into summary SWOT items
STAGE 1
Use SWOT - Process the SWOT to set priorities
Organizational Goals - Determine your organization’s core purpose
KPIs - Select key performance indicators to track progress
Department Goals - Cascade org goals to department (12 months)
Team Member Goals - Cascade department goals to individuals
Budget - Align a one year budget with the plan
STAGE 2
Mission - Determine your organization’s core purpose
Value - Identify your core beliefs
Vision - Create an image of what success looks like in 5 years
Competitive Advantages - Solidify your unique position
Org. Wide Strategies - Establish the approach for how you will succeed
Long-Term Objectives - Develop a 3 year balanced framework of (maximum)
6 objectives
Forecast - Develop a 3 year financial projection
STAGE 2
STAGE 3
Rollout - Communication strategy to whole organisation
Set Calendar - Establish schedule for progress reviews
Adapt Quarterly - Hold Progress reviews and modify
Update Annually - Review end of year, plan next year
DETERMINE POSITION
DEVELOP STRATEGY
BUILD THE PLAN
MANAGE PERFORMANCE
STAGE 1 OUTCOME
STAGE 2
STAGE 3
Deep dive into company information determining current position.
An extensive report on the current position of the US business.
2 day Lockdown event to create the strategy, communications and engagement plan
Creation of a communication vehicle to disseminate the strategy to the organisation
A strategy, communications and engagement plan
Alignment and engagement within your organisation
OUTCOME
OUTCOME
Pre-Event The Lockdown Event Post-Event
DeterminePosition
DevelopStrategy
Build thePlan
ManagePerformance
Interviews with leadership teams
Input taken from survey results
Facilitated session to create the strategyCommunicate to the whole organisation
C R E A T I N G A N A L I G N E D L E A D E R S H I P T E A M
100
0m
m
1000mm
01 - ASTRAZENECA, THE LOCKDOWN “BIG PICTURE”
Logo Design
This sales pitch was created for the Pharmaceutical giant Astrazeneca. It was important for me to create a memorable presentation tool that also felt familiar to the company’s brand.
02 - IMD BUSINESS SCHOOL, BEING INNOVATIVE WITH BILL FISCHER
Breaking IMD’s previous boundaries, I helped to create their first digital course. The 8-week course uses a combination of illustration, motion graphics and live footage to enable the student to engage in visual learning.
03 - DELIVERERS, BRANDING GUIDELINES
In my downtime working at Deliverers I took it upon myself to collate all branded work and put together brand guidelines to ensure consistency in the company’s resources and in future projects.
04 - DELOITTE, GLOBAL NEW PARTNERS SEMINAR PLATFORM
I worked closely with a Developer to refresh an existing micro-site platform that could easily be edited and re-branded for multiple projects. The initial design was created for Deloitte to host pre-event videos and games.
05 - ANDY HOSEGOOD, PIN UP ARTIST 2014 CALENDAR
This limited edition calendar was created using a range of Adobe Creative Suite programs, featuring a typographical cover and a simple date system to not detract attention from the paintings.
06 - DELOITTE, PEER COMMUNITY DOCUMENT
I worked alongside another Graphic Designer to typeset multiple internal documents for Deloitte. It was key in this project to communicate clearly with my colleague to ensure each booklet followed the same guides and style.
07 - PRIMA DONNA PETS, WEBSITE & BUSINESS CARDS
Brentwood-based pet boutique Prima Donna Pets wanted to create an eye-catching website based around their existing branding. I made sure to stay true to their current brand while introducing new elements and a simple navigation.
Business Cards Website
Service Icons
“TURNING A MARKET ACCESS CHALLENGE INTO A BEST IN CLASS ASSESSMENT AND A MARKET EVENT” (THOMAS LANG AND STEFANIE TUEBBEN, MSD GERMANY)
THE CHALLENGE: DPP-4 ASSESSMENT
proudly presents:
THE AMNOG DPP-4 CHALLENGE
STARRING
MSD GERMANY GLOBAL DIABETES FRANCHISE GHO MRL
THE CHALLENGE: DPP-4 ASSESSMENT
Entire DPP-4 class called for assessment in summer 2012: Sitagliptin, Saxagliptin & Vildagliptin
300,000 pages dossier assembled by MSD Germany in close collaboration with and support from global cross-functional teams
G-BA issued appraisal for Sitagliptin in October 2013: Most favourable outcome for any diabetes drug in Germany in last eight years.
Recently, Novartis announced withdrawal of Vildagliptin from German market following unfavourable assessment outcome in AMNOG review
MSD SITAGLIPTIN AMNOG DOSSIER
| WHAT WE ARE WORKING FOR IS…
Press releases
| WHAT WE DON‘T WANT TO SEE FOR OUR PRODUCTS…
Advantage for Sitagliptin
New Bayer drug flopped in important benefit assessmentWithdrawn from market: Canagliflozin, Vildagliptin, Vildagliptin/Metformin FDC,Linagliptin, Lixisenatide
Bestandsmarkt: Novartis nimmt Vildagliptin vom Markt
Zum 1. Juli 2014 stellt Novartis hierzulande den Vertrieb seiner Antidiabetika mit dem Wirkstoff Vildagliptin ein. Wie der Schweizer Pharmakonzern heute bekannt gab, reagiere man damit auf die unbefriedigenden Preisverhandlungen mit dem GKV-Spitzenverband für die Mittel Galvus®/Eucreas® (Vildagliptin/Vildagliptin plus Metformin). Zuvor hatte der Gemeinsame Bundesausschuss (G-BA) im Rahmen der Nutzenbewertung des Bestandsmarkts für den Wirkstoff Vildagliptin und die Wirkstoffkombination keinen Zusatznutzen gegenüber der zweckmäßigen Vergleichstherapie mit einem Sulfonylharnstoff festgestellt. Dies hatte für den Hersteller zur Folge, dass die Höhe des Erstattungsbetrags mit den Kassen verhandelt werden musste.
UNSUCCESSFUL
WITHDRAWN
Vildagliptin WITHDRAWN from German market
| DIABETES ASSESSMENTS 2006-14
JANUVIA/JANUMET ASSESSMENT OUTCOME
POWER CAMPAIGN FOR DIABETES:FOCUSED, SIMPLE & FAST EXECUTION
POWER 2.0(PRICE NEGO)
JANUVIA® & JANUMET®: EVERY MILESTONE TURNED INTO A MARKET EVENT
Januvia & Janumet
Xelevia & Velmetia
Galvus & Eucreas
Jalra & Icandra
Onglyza &Komboglyze
0.0%
1.0%
2.0%
3.0%
4.0%
5.0%
6.0%
7.0%
8.0%
9.0%
Jan-1
3
Feb-13
Mar-13
Apr-13
May-13
Jun-1
3
Jul-1
3
Aug-13
Sep-13
Oct-13
Nov-13
Dec-13
Jan-1
4
Feb-14
Mar-14
Apr-14
May-14
Jun-1
4
Jul-1
4
Mar
ket S
hare
(in
Pres
crip
tions
)
POWER 1.0 (G-BA) JMT = NO 1(VILDA EXIT)
VILDAGLIPTIN EXIT : DIABETES CAMPAIGN JULY 1ST:FAST AND POWERFUL EXECUTION AS KEY TO SUCCESS
SITAGLIPTIN: THE SUCCESS STORY CONTINUES
Sitagliptin MSD
Sitagliptin BC
Saxagliptin
Sitagliptin Total
Vildagliptin
Xigduo
Invokana
Forxiga
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
45,000
Jan-
11Fe
b-11
Mar
-11
Apr-
11M
ay-1
1Ju
n-11
Jul-
11Au
g-11
Sep-
11O
ct-1
1N
ov-1
1D
ec-1
1Ja
n-12
Feb-
12M
ar-1
2Ap
r-12
May
-12
Jun-
12Ju
l-12
Aug-
12Se
p-12
Oct
-12
Nov
-12
Dec
-12
Jan-
13Fe
b-13
Mar
-13
Apr-
13M
ay-1
3Ju
n-13
Jul-
13Au
g-13
Sep-
13O
ct-1
3N
ov-1
3D
ec-1
3Ja
n-14
Feb-
14M
ar-1
4Ap
r-14
May
-14
Jun-
14Ju
l-14
Sale
s in
EU
R 0
00
CU/D
ay in
000
Jul-
12
Aug-
12
Sep-
12
Oct
-12
Nov
-12
Dec
-12
Jan-
13
Feb-
13
Mar
-13
Apr-
13
May
-13
Jun-
13
Jul-
13
Aug-
13
Sep-
13
Oct
-13
Nov
-13
Dec
-13
Jan-
14
Feb-
14
Mar
-14
Apr-
14
May
-14
Jun-
14
Jul-
14
15,000
20,000
25,000
30,000
35,000
40,000
SU DPP-4
July 1st
October 1st April 1st
2 – 5 H AFTER AFTER THE NEWS:More than 400 reps were equipped with the materials and messages. A big Multi-ChannelCampaign started.
OPTIMIZE TARGETING: IDENTIFICATION OF VILDAGLIPTIN HEAVY PRESCRIBERS
> Special Targeting assessment done in June
ONE STRONG MESSAGE FOR ALL ACTIVITIES
> 2h after Vildagliptin news release: more than 400 reps were equipped with the relevant materials and ready to go
CLEAR REACH AND FREQUENCY OBJECTIVES
> Close collaboration between PC sales forces to cover the right customers in the right sequence > Rented sales force in high potential vilda segments
EXTRA SALES INCENTIVE BASED ON SPECIAL MARKET SHARE ACHIEVEMENT
40%
20%
Mar 14
67% 83%
Jul 14
0%
80%
100%
60%
Mar
ket S
hare
SaxagliptinSitagliptin Total Vildagliptin
NO. 1: DPP-4
BEST IN DIABETES:- IQWiG- G-BA- Price Neg.- Execution
SOV (VS. 13):+ 75% IN FTES+ 257% IN CALLS
Source: IMS National Prescription Index
98 FEET
+ 72.2 MILL. € IN 2014 & 2015
67% 83%
Insulin GlargineInsulin DetemirPioglitazoneRosiglitazoneExenatide Insulin AspartInsulin GlulsineInsulin Lispro
ADDED BENEFITS (IQWIG) 1. Sitagliptin (Metformin add-on)2. Sitagliptin/Metformin FDC (Monotherapy)
ADDED BENEFITS (G-BA)1. Sitagliptin (Monotherapy)2. Sitagliptin (Metformin add-on)3. Sitagliptin/Metformin FDC (Monotherapy)
1. Saxagliptin (Metform. add-on)2. Saxagliptin/Metformin FDC (Monotherapy)
NO (ADDED) BENEFITSCanagliflozinDapagliflozin/Metformin FDCDapagliflozinVildagliptin/Metformin FDCVildagliptinLixisenatideLinagliptin NatelinideRepalinide
AHA!2.0 ‘TODAY IS TIME FOR CHANGE’
MSD FORUM HEALTH CARE PARTNER: AN UNPARALLELED 4 YEARS ONGOING SUCCESS STORY
OBJECTIVE: Bringing together health policy stakeholders to learn from each other and to stand up for an efficient and effective healthcare system
Key Note Speaker:Ulrike FlachParliamentary State Secretary MoH
Patronage:W. HeubischBavarian State Minister for Science, Research & Art
Patronage:Daniel Bahr Minister of Health
Patronage:Hermann GroeheMinister of Health
2011HOTEL HILTON MÜNCHEN
2012IN HAAR
2013IN HAAR
2014SEPTEMBER 17TH IN HAAR
80 participants & Award announcement
135 participants & 50 Award applications
140 participants & 35 Award applications
180 participants & 53 Award applications
NOMINATED FOR 2012 HEALTH CARE AWARD
• Comprehensive care program for T2D prevention• FINDRISK (diabetes risk) screening by GP• Includes individual health targets for patients
A LANDMARK INITIATIVE FOR GERMAN HEALTH CARE SYSTEM & MSD – WE MADE IT POSSIBLE!
Program leading Physicians
Germany‘s largestsick-fundsMSD - As trusted partner
Physician Networks
Patronage Regional MoH Local SHI - Physician Association
RECORD IMPLEMENTATION
1. IDENTIFIED AS GERMAN 3P PROJECT (MSD HC AWARD)
2. OBJECTIVE SETTING & INTERNAL APPROVAL
3. ETHICS COMMITTEE APPROVAL: JANUARY 2014
4. CONTRACT SICK-FUNDS & PHYSICIAN ASSOCIATION SIGNED
5. PHYSICIAN REGISTRATION & INSUREE ENROLLMENT
6. EVALUATION & PUBLICATION
PROGRAM LAUNCH JULY 1ST, 2014
• ENABLER: AHA!-PILOT & MSD-HEALTHCARE AWARD
• CLOSE CROSS-FUNCTIONAL COLLABORATION
• 500 TARGETED PHYSICIANS & 10.000 INSUREES
OCT. 1ST 2014: 223 PHYSICIANS
REGISTERED & 119 INSUREES ENROLLED
CREATES UNIQUE ATTENTION IN DISCUSSIONS WITH STAKEHOLDERS
DR. MED. PETERSEN DIABETOLOGIST & PROJECT OWNER
PILOT RESULTS• 1.200 participants during 2007 – 2011• Significant weight loss• 7 % unreported T2D identified Standard of care treatment initiated, for new diagnosed T2D patients
200
0m
m
3000mm 850mm
08 - MSD, EUCAN DIABETES EVENT “BIG PICTURES”
This is 2 of 24 large format prints that were created for a pharmaceutical event in Germany. We were supplied with Powerpoint documents from each client and asked to re-purpose their work using info-graphics and diagrams.
